Topics
Diffuse midline glioma | Treatment | Targeted therapy | Selumetinib
Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy > Selumetinib
Saito R, Hanihara M, Okamoto T, Fujihara M, Muto Y, Kazama H,
Mochizuki K, Yoshioka H, Kinouchi H.
Antitumor
Effect of Selumetinib for Brainstem Glioma in an Adult With NF1: A
Case Report.
Neurosurg
Pract. 2025 Oct 13;6(4):e000175. doi:
10.1227/neuprac.0000000000000175. PMID:
41163739. Case report. ˍ